Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 5 results out of 5

Company Profiles

Access comprehensive reports covering all the major players in the pharmaceutical industry

Buy Now

Data Insights

Onureg is under clinical development by Bristol-Myers Squibb and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to...

Data Insights

Onureg is under clinical development by Bristol-Myers Squibb and currently in Phase I for Refractory Acute Myeloid Leukemia. According to...

Data Insights

Onureg is under clinical development by Bristol-Myers Squibb and currently in Phase II for Solid Tumor. According to GlobalData, Phase...

Data Insights

Onureg is under clinical development by Bristol-Myers Squibb and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to...

Data Insights

Onureg is under clinical development by Bristol-Myers Squibb and currently in Phase I for Refractory Acute Myeloid Leukemia. According to...